Literature DB >> 24428610

Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Ruizhong Shen1, Phillip D Smith.   

Abstract

Resistance to HIV-1 infection in HIV-1-exposed sero-negative (HESN) persons offers a promising opportunity to identify mechanisms of 'natural' protection. Unique features of the mucosa in particular may contribute to this protection. Here, we highlight several key issues pertaining to the mucosal correlates of protection in HESN persons, including humoral immune responses, mechanisms of mucosal HIV-1 neutralization, immune cell activation, and role of the microbiota in mucosal responses. We also discuss mucosal model systems that can be used to investigate the mechanisms of resistance in HESN subjects. A clear understanding of the mucosal correlates of protection against HIV-1 in HESN persons will provide critical new insights for the development of effective vaccine and microbicide strategies for the prevention of HIV-1 transmission.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  HESN; cervicovaginal lavage; genital; immune activation; microbiota; mucosal secretion

Mesh:

Substances:

Year:  2014        PMID: 24428610      PMCID: PMC4101071          DOI: 10.1111/aji.12202

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  119 in total

1.  Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.

Authors:  L Lopalco; C Pastori; A Cosma; S E Burastero; B Capiluppi; E Boeri; A Beretta; A Lazzarin; A G Siccardi
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-20       Impact factor: 2.205

2.  Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells.

Authors:  Vincent Holl; Maryse Peressin; Thomas Decoville; Sylvie Schmidt; Susan Zolla-Pazner; Anne-Marie Aubertin; Christiane Moog
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Authors:  Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 4.  Early HIV-1 target cells in human vaginal and ectocervical mucosa.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2010-12-01       Impact factor: 3.886

5.  Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.

Authors:  L Dorrell; A J Hessell; M Wang; H Whittle; S Sabally; S Rowland-Jones; D R Burton; P W Parren
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

6.  Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis.

Authors:  John J Schellenberg; Catherine M Card; T Blake Ball; Jane Njeri Mungai; Erastus Irungu; Joshua Kimani; Walter Jaoko; Charles Wachihi; Keith R Fowke; Francis A Plummer
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

Review 7.  Genetic correlates of protection against HIV infection: the ally within.

Authors:  L Piacentini; M Biasin; C Fenizia; M Clerici
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

8.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

9.  Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

Authors:  J W Burns; M Siadat-Pajouh; A A Krishnaney; H B Greenberg
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

10.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.

Authors:  Habtom H Habte; Anwar S Mall; Corena de Beer; Zoë E Lotz; Delawir Kahn
Journal:  Virol J       Date:  2006-11-24       Impact factor: 4.099

View more
  12 in total

Review 1.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

2.  HIV-1 envelope glycan moieties modulate HIV-1 transmission.

Authors:  Ruizhong Shen; Milan Raska; Diane Bimczok; Jan Novak; Phillip D Smith
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 3.  Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.

Authors:  Sandra Milena Gonzalez; Natalia Andrea Taborda; María Teresa Rugeles
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

4.  Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41.

Authors:  Maxence Duchemin; Daniela Tudor; Andréa Cottignies-Calamarte; Morgane Bomsel
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

Review 5.  Mucosa: Key Interactions Determining Sexual Transmission of the HIV Infection.

Authors:  Sandra M Gonzalez; Wbeimar Aguilar-Jimenez; Ruey-Chyi Su; Maria T Rugeles
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

Review 6.  HIV-1 Entry and Prospects for Protecting against Infection.

Authors:  Jean-François Bruxelle; Nino Trattnig; Marianne W Mureithi; Elise Landais; Ralph Pantophlet
Journal:  Microorganisms       Date:  2021-01-22

Review 7.  Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Authors:  Iskra Tuero; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2014-08-15       Impact factor: 5.048

Review 8.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27

9.  Transient Increases in Inflammation and Proapoptotic Potential Are Associated with the HESN Phenotype Observed in a Subgroup of Kenyan Female Sex Workers.

Authors:  Marcel Gluchowski; Xiaoqiong Yu; Bernard Abrenica; Samantha Yao; Joshua Kimani; Renée N Douville; Terry Blake Ball; Ruey-Chyi Su
Journal:  Viruses       Date:  2022-02-25       Impact factor: 5.048

10.  Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.

Authors:  Ruey-Chyi Su; Andrew Plesniarski; Zhujun Ao; Joshua Kimani; Aida Sivro; Walter Jaoko; Frank A Plummer; Xiaojian Yao; Terry Blake Ball
Journal:  Mol Ther Nucleic Acids       Date:  2015-10-27       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.